Could OTC Cialis for erectile dysfunction reach the US?

Sanofi's consumer healthcare unit Opella could finally be able to bring an OTC PDE-5 inhibitor for erectile dysfunction to the US market.

Sanofi's plans for OTC Cialis hit a snag in US

It has been eight years since Sanofi licensed rights to an over-the-counter version of erectile dysfunction (ED) drug Cialis from Eli Lilly, and the FDA has just thrown a spanner into its p

Humira tops list of drugs with unwarranted US price hikes